Work Group 1 Telecommunication develops and maintains standards and guidelines to accommodate the collection, transmission, and processing of information that may be exchanged electronically or in written formats. The information exchanged may be used for, but is not strictly limited to, such purposes as administering and certifying eligibility, establishing prior authorization for products and services, pharmacy claim billing, payment determination, denial of compensation with explanations, drug use review and the exchange of adjudicated data between business associates.
Work Group 2 Product Identification deals with issues relating to the identification of drugs and health related products within NCPDP’s stated mission. Identification consists of how the product is billed (billing units, quantity designations), product identification systems, and any type of descriptive data which serves to uniquely identify a product with the intent to establish standards for product identification such that there is no ambiguity in distinguishing one product from another.
Work Group 7 Manufacturer and Associated Trading Partner Transaction Standards develops, monitors, and maintains standards for the electronic exchange of data amongst manufacturers and trading partners to facilitate business processes. Additionally, the work group promotes implementation and education of the standards.
Work Group 9 Government Programs, in conjunction with Work Group 1 Telecommunication and other Work Groups, as necessary, guides and advises federal and state pharmacy programs and their agents on NCPDP standards. WG9 also supports data processing initiatives, and provides design alternatives for standards, which support government requirements.
Work Group 10 Professional Pharmacy Services supports the pharmacist’s individual and collaborative planning, delivery, documentation and quality assessment of patient care services through the development and distribution of standards, standards-based templates, and implementation guides. These documents/tools in conjunction with the publication of best practices recommendations encourage patient engagement, foster patient safety and support consistent delivery of patient care services to optimize outcomes.
WG10 strives to support pharmacists in utilizing their unique training and expertise to provide patient care services related to the appropriate use of medications. Patient care services are provided in many different practice settings and include activities such as medication therapy management, clinical reconciliation (medication, allergies and problems), patient immunization management, disease state monitoring, adverse drug event reporting and therapy adherence program management. Pharmacists contribute to improving patients’ health by providing patient care services as authorized by license and allowed under their scope of practice and collaborative practice agreements.
WG2 Product Identification Goals
For a list of acronyms, please see the Acronym Dictionary
- Promote NCPDP membership attendance and active participation in work group meetings and task groups.
- Continue to maintain and enhance the Billing Unit Standard (BUS) Implementation Guide for NCPDP members and other impacted parties (such as government agencies, manufacturers).
- Encourage attendance and participation by pharmaceutical manufacturers to address resolution of billing issues before product launch.
- Collaborate with other work groups to facilitate mutual goal achievement:
- WG1 Telecommunication to maintain consistent product identifiers and facilitate interoperability between product identifiers used throughout the Telecommunication Standard.
- WG7 Manufacturer and Associated Trading Partner Transaction Standards to increase cooperation between NCPDP and the Centers for Medicare and Medicaid Services (CMS).
- WG11 ePrescribing and Related Transactions to maintain consistent product identifiers and facilitate drug database consistency.
- MC Maintenance and Control to support MC Education-Legislation and Regulation Task Group when new legislation is introduced regarding issues relevant to the work group.
- Review and adjudicate Quantity Unit Information Communication (QUIC) Forms.
- Monitor and report on issues relating to the scope of WG2 including but not limited to National Committee on Vital and Health Statistics (NCVHS), Food and Drug Administration (FDA), Health Level Seven International (HL7®), National Library of Medicine’s (NLM) RxNorm, and bar code activity.
- Continue collaboration with American Society of Health-System Pharmacists (ASHP), FDA, NCVHS, CMS, NLM, United States Pharmacopeial Convention (USP), United States Adopted Names Council (USAN) and HL7®.
- Continue to provide clarification and education on the structure of the National Drug Code (NDC), Universal Product Code (UPC), Unique Device Identifier (UDI) and the National Health Related Item Code (HRI) as they are formatted for use within the NCPDP standards. Monitor and participate in the development of new identifiers and provide input on standards conformance when appropriate.
- Provide input to the FDA on their continued development of the enhancement to the Structured Product Labeling (SPL) and ongoing guidance to support the use of the Billing Unit Standard (BUS) within the SPL.
- Determine and apply the BUS to new products and to existing products that have had labeling changes.
- Review and modify, where appropriate, billing unit exceptions within the BUS.
- Monitor WG2 task groups to ensure they are tracking scope, goals, and deliverables. Disband task groups that have completed their work.
- Maintain and formulate frequently asked questions (FAQs) for the Product Identifier Standard to provide guidance on how they are used in dispensing, purchasing, administration, medical records, reimbursement, etc. within the industry.
- Review Data Element Request Forms (DERFs) and adjudicate ballots pertaining to standards for which this work group is responsible.
- Analyze, develop and execute Webinar opportunities for WG2 standards in coordination with Educational Programs Advisors Group.
WG2 Product Identification Scope
- Work Group 2 Product Identification deals with issues relating to the identification of drugs and health related products within NCPDP’s stated mission. Identification consists of how the product is billed (billing units, quantity designations), product identification systems, and any type of descriptive data which serves to uniquely identify a product with the intent to establish standards for product identification such that there is no ambiguity in distinguishing one product from another.